Conclusions: Aripiprazole demonstrated its efficacy in maintaining abstinence from metamphetamine use in Thai patients with metamphetamine dependence following metamphetamine psychosis. It was found to be safe and well tolerated. 
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Abstract
The autism susceptibility candidate 2 (AUTS2) gene has been implicated in multiple neurological disorders including autism. Recent genome-wide analysis has indicated that the AUTS2 gene is involved in the regulation of alcohol consumption. Therefore, we hypothesized that AUTS2 might be associated with the development of alcohol dependence, and focused on two single nucleotide polymorphisms (rs6943555 and rs9886351) in the AUTS2 gene, which have been studied extensively. In this exploratory study, we compared the genotype and allele frequencies of two polymorphisms in the AUTS2 gene between patients with alcohol dependence and healthy control subjects living in a Japanese provincial prefecture. We also examined whether or not the haplotypes consisting of these polymorphisms are related to alcohol dependence. The subjects of this study consisted of 64 patients with alcohol dependence (male: 50, female: 7, not available: 7; 57.34 ± 10.18 years) and 75 unrelated healthy people (male: 23, female: 52; 35.36 ± 9.06 years). The AUTS2 genotypes were determined by the polymerase chain reaction (PCR) -restriction fragment length polymorphism (RFLP) method. The study was approved by the ethics committees of the Tokyo Metropolitan Institute of Medical Science and Azabu University. No significant differences in the genotype and allele frequencies of the polymorphisms AUTS2 rs6943555 and rs9886351 were found between alcohol dependence and control subjects. On the other hand, the frequencies of the AUTS2 haplotypes were significantly different between them (p = 0.0187), and the patients with alcohol dependence showed a higher frequency of the rs6943555 and rs9886351 A-A haplotype as compared with the control group (26.73% of patients, 15.03% of controls). This suggests that the rs6943555 and rs9886351 A-A haplotype might affect the vulnerability to alcohol dependence pathogenesis. Further studies are needed to confirm the reproducibility of the results of this study with increased numbers of subjects.
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SORCS2 regulates alcohol withdrawal severity and excitatory synaptic transmission USA; email, joel.gelernter@yale.edu; phone, fax, Abstract Objective: Efforts to promote the cessation of harmful alcohol use are hindered by the affective and physiological components of alcohol withdrawal (AW), which can include life-threatening seizures. Although previous studies of AW and relapse have highlighted the critical importance of the N-methyl-D-aspartate receptor (NMDAR) subunit GluN2B and the detrimental role of stress, little is known about genetic risk factors. We therefore conducted genetic and neurobiological studies to identify and characterize novel risk loci. Methods: We performed a genome-wide association study (GWAS) of AW symptom count in uniformly assessed subjects with histories of serious AW, followed by additional genotyping in independent subjects, and bioinformatic analyses. We used genetically modified mouse neuronal cultures to conduct electrophysiological and pharmacological studies of neurobiological systems implicated by the GWAS. Results: The top association signal for AW severity was in sortilin-related gene SORCS2 on chromosome 4 (European-American meta-analysis n = 1,478, P = 4.3 x 10 -9 ), and the same risk allele also predicted more severe clinical outcomes in seizure disorder patients participating in a randomized trial of anticonvulsant effectiveness (n = 654, P = 3.2 x 10 -3 ). In humans, SORCS2 is most highly expressed in the nervous system, and bioinformatic analyses showed that the SORCS2 risk haplotype disrupts transcription factor (TF) binding motifs within a stress hormoneregulated enhancer element active in human hippocampus. In mouse hippocampal preparations, we demonstrate that SorCS2 is a key regulator of GluN2B-mediated synaptic responses. Conclusion: These translational findings identify new synaptic regulatory processes, and provide novel targets for managing the aversive consequences of abrupt alcohol cessation.
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High-dose zolpidem dependence and detoxification from withdrawal symptoms using diazepam
St. Andrew's Hospital, Republic of Korea
Abstract Objective of the study: Zolpidem is a nonbenzodiazepine hypnotic for the treatment of insomnia, and known as a relatively safe medication. However, there have been several case reports of zolpidem abuse and dependence these days. Even though some withdrawal symptoms like seizures can occur, there was no standard detoxification method until now. Methods used: We reviewed the previous researches about high-dose zolpidem addiction and proposed treatment, and the clinical case. Summary of results: A high dose of zolpidem has similar pharmacologic properties as the rest of benzodiazepines, even though the usual dose of zolpidem has a selectivity to type 1 benzodiazepine receptor. So, some cases of high-dose Zolpidem dependence can be treated by conventional benzodiazepines, such as diazepam. Actually, diazepam tends to be avoided because of complicated pharmacological properties and potential risks like respiratory suppression, iatrogenic dependence. But diazepam is still one of candidate medication for managing withdrawal symptoms of benzodiazepine dependence, and also, nonbenzodiazepine hypnotics in the clinical setting. Conclusions reaches: We report a rare case of high-dose addiction and successful detoxification by cross-titration with diazepam. Key words: addiction, dependence, detoxification, diazepam, withdrawal, zolpidem.
